MedTrace Logo

A1c Discordance in Diabetes Patients

NCT01213277 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2011-07-26

No results posted yet for this study

Summary

HbA1c is used as a gold standard to see whether patients have optimal glycemic control. Today, many physicians rely solely on HbA1c to change medication. However, there is a select group of patients that have low average glucose levels but high HbA1c levels. The investigators believe that these patients are fast glycators meaning that they incorporate sugar into their hemoglobin faster than normal. The investigators want to determine whether these patients are fast glycators.

Conditions

Interventions

OTHER

Fast Glycator

The subjects enrolled in this study will have a fructosamine test and blood drawn to see whether they are fast glycators

OTHER

Control

These patients will have their blood drawn to know what the normal glycation rate is in diabetic patients

Sponsors & Collaborators

  • Endocrine Research Society

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01213277 on ClinicalTrials.gov